Furthermore, we found that gavaging CDCA increased the expression of Scd1 in the brain and the levels of its products C16:1 and C18:1, which indicated that CDCA-SCD1 acts as an intermediate mediator in the impact of the colitis microbiome on the brain. Here, SCD is linked to colitis.